hormones and growth - notes Flashcards

1
Q

hormones most relevant in growth

A
GH
thyroid hormones
insulin
androgens
estrogens
glucocortocoids
peptide growth factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

why would malnutrition prevent growth?

A

malnourished tissues are refractory to the actions of many hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

growth hormone

A

1: promotion of skeletal growth
2: stimulation of soft tissue growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

GH on linear growth

A

affects chondrogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GH on soft tissue growth

A

increases cell number and size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HGH and insulin

A

antagonizes effects of insulin on liver and muscle

directly or indirectly via somatomedins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

forms of HGH

A

major forms: one of 22000 D and one of 20000 D
produced by anterior pituitary
also larger form and several smaller forms in pit
big and big-big in plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

somatotrope cells

A

produce HGH
most numerous in anterior pituitary
predominate in lateral wings where lactotrope cells also found
acidophiles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GH on metabolism

A

1: increased protein synthesis and AA uptake by tissues (promotes positive N2 balance)
2: increased RNA and DNA synthesis
3: increased connective tissue growth and skeletal growth
4: increased acid mucopolysaccharide formation in skin and cartilage
5: hyperglycemia via antiinsulin or diabetogenic action
6: increased retention of Na, K, Cl, Mg, PO4, and Ca
7: increased lipolysis => increased fat mobilization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

changes in GH effects on metabolism over time

A

for first few minutes, exhibits insulin-like activities on glucose uptake and on free FA utilization
then changes to anti-insulin effects such as increasing plasma glucose levels and increasing circulating FFA
initial effects due to somatomedins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what effect would removal of the pituitary have on adolescents with juvenile diabetes

A

would reduce insulin requirements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how is commercially available HGH produced?

A

recombinant technology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

stimulatory factors in HGH release

A

hypoglycemia

1: hypothalamus is directly responsive to circulating glucose levels - produce GHrH, somatotropin releasing factor, somatocrinin => GH release
2: increased blood levels of AA, esp. arginine - GH levels increase 2-4 hours after a meal
3: deep sleep (stage 3 and 4) - turned off by REM sleep
4: diurnal variation in GH release - peak levels in evening and early morning
5: exercise - likely correlates with FFA utilization for energy
6: GHRH from hypothalamus
7: brain GHRP/gerlin (growth hormone releasing peptide) => increased GHRH, decreased somatostatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are provocative tests for hGH?

A

insulin, arginine, L-dopa, conidine

must use at least two and take multiple samples throughout day because levels fluctuate so much

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

inhibitory factors in HGH release

A

1: REM sleep
2: somatomedins (IGFs) - hGH increases production - mediate effects of hGH on tissues - ones released by liver are mainly responsible for circulating levels - negative feedback
3: primary hypothyroidism via inhibitory effects of excessive TRH on somatotropes
4: high FFA levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

growth hormone deficiency

A

usually associated with deficiencies of other pituitary hormones too
pubertal development delayed
growth stunted => dwarfism
must treat before full bone maturation
usually due to hypothalamic dysfunction or pituitary lesion or failure of tissues to respond to GH (s.a. laron dwarfism and african pigmyism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

laron dwarfism and african pigmyism

A

GH deficiency syndromes
HGH levels are high and somatomedin leves are subnormal
either receptor or post-receptor defect leading to the symptoms of GH deficiency (ie tissues aren’t responding properly to GH)
somatomedin C levels low in hypopituitary dwarfs
can use it to treat this sometimes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

growth hormone hypersecretion

A

usually due to tumor of pituitary
can cause pituitary gigantism if before epiphyseal plates sealed
if after bone maturation, acromegaly
plasma HGH and somatomedin C levels elevated in both
treat with microhypophysectormy, radiation, or drugs that inhibit HGH secretion (s.a. bromocriptine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

acrogmegaly

A

pituitary tumor after epiphyseal plates have fused
connective tissue proliferation
dermal overgrowth
enlargement of extermities
plasma HGH and somatomedin C levels elevated
treat with microhypophysectormy, radiation, or drugs that inhibit HGH secretion (s.a. bromocriptine)
somatomedin C levels elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

insulin in growth

A

hyperinsulin before or after birth => excessive growth
deficiency => growth failure
fills permissive role
affects possible due to its structural similarity to somatomedin C (IGF-1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

nerve growth factor

A

may mediate role of thyroid hormones in development of brain during last part of gestation and for several months of postnatal development (for growth of ganglia in fetal life, maintaining sympathetic nervous system postnatally)
118 AA, derived from dimer with 3 subunits
beta subunit is biologically active
produced by number of tissues
differentiating factor
production stimulated by androgens and thyroid hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

thyroid hormones in neural development

A

required for brain development during last part of gestation and for several months of postnatal development
may be mediated by NGF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

hypothyroidism and growth

A

children with this have severely retarded growth
increase protein and RNA synthesis, possibly increase in DNA synthesis
could have permissive role
since HPA mechanisms controlling GH and TH release are interrelated, problems in TH may reduce stores and release of GH
also appear to prime tissues to respond to somatomedins

24
Q

sex hormones in growth

A

promote protein synthesis and hence N2 retention
androgens responsible for adolescent growth spurt
androgenation associated with muscular growth
but need GH to have effect - act synergistically to enhance linear growth
promote bone maturation that ultimately leads to closure of plates

25
Q

estrogen on growth

A

may have some inhibitory effect, possible mediated by reduction of somatomedin release in response to GH

26
Q

glucocorticoids in growth

A

hormones of adrenal cortex
when in high amounts, catabolic effect on peripheral growth
but cortisol has anabolic effects on liver and is required as permissive agent in some processes
interferes with action of somatomedin C on cartilage
normally negative effects on protein synthesis can become synthesis-enhancing when the hormones given together with certain tissue growth factors

27
Q

cortisol in growth

A

has anabolic effects on liver and is required as permissive agent in some processes
interferes with action of somatomedin C on cartilage

28
Q

adrenal virilizing hyperplasia

A

one condition in which glucocorticoids can be used to promote growth, despite the fact that glucocorticoids are generally catabolic

29
Q

somatomedins

A

peptide growth factor
mediate growth-promoting actions of GH
5: A, B, C, IGF-1, IGF-2

30
Q

somatomedin B

A

not regulated by GH

promotes thymidine incorporation in culture, but is essentially an antiprotease

31
Q

somatomedin A

A

release regulated by GH
neutral peptide with no disulphide bonds
promotes growth of cartilage and thymidine incorporation by cells

32
Q

somatomedin C and IGF-1

A

now thought identical
structurally related to proinsulin
70 aa, can be divided into 3 domains (A, B, C)
A and B about 50% identical with proinsulin
structure remains intact (A, B, and C not divided)
serum levels provide some index of GH activity on tissue targets - leves rise with age in prepubertal children, peak during puberty, and fall in adulthood
levels low in hypopituitary dwarfs, elevated in acromegaly

33
Q

IGF-1 and IGF-2

A

whats though of as somatomedins
structurally related to proinsulin
released from liver by GH
likely mainly responsible for circulating levels of peptides
tissues levels increase dramatically in response to hGH (more so than plasma levels) - may chiefly be paracrine

34
Q

IGFBPs

A

bind somatomedins in plasma - 85% bound

produced by liver and GH target tissues

35
Q

plasma levels of IGF-1 and IGF-2

A

in normal adults:
IGF-1 levels average about 200 ng/mL
IGF-2 levels average about 650 ng/mL

36
Q

IGF-2 receptor (type 1)

A

on cell membranes
alpha and beta subunits linked by disulfide bonds
insulin can also bind, but with low affinity (IGF-1 also has weak affinity for insulin receptors)

37
Q

actions of IGF-1 in cells

A

1: stimulates DNA synthesis and cell division
2: promotes sulphate incorporation into proteoglylcans of cartilage and connective tissue
3: differntiation of myoblasts into myotubules in muscle
4: myoblast proliferation
5: can also have insulin-like actions
6: in adipose tissue can stimulate glucose oxidation and the synthesis of lipids

38
Q

IGF-2 receptor

A

type 2 receptor

insulin has no binding affinity

39
Q

actions of IGF-2 in cells

A

1: IGF-2 has higher binding affinity for insulin receptor than does IGF-1 so has more potent insulin-like actions on muscle and adiopse
2: promotes cell division
3: promotes RNA synthesis
4: promotes protein synthesis

40
Q

platelet derived growth factor (PDGF)

A

basic peptide
2 chains (a, B) united by disulphide bridge
may be involved in development of atherosclerosis

41
Q

actions of PDGF on growth

A

1: promotes growth of fibroblasts and SMCs by acting as a competence factor - once cells competent, they can undergo mitosis in response to appropriate stimuli (s.a. that from IGF-1 or EGF)

42
Q

PDGF receptor

A

membrane protein

activation leads to increased tyrosine kinase activity and increased conversion of membrane phospholipid to IP3 and DAG

43
Q

fibroblast growth factor (FGF)

A

peptide
isolated from pituitary and brain
seems to stimulate cell proliferation by acting as a competence factor

44
Q

epidermal growth factor (EGF) structure

A

53 aa, 3 disulphide bridges
derived from 1200 AA precursor (2 molecules of EGF and 2 molecules of a binding subunit)
binding subunit cleaves precursor to form an active peptide that has paracrine or autocrine role
produced by many different tissues throughout body

45
Q

EGF actions

A

paracrine or autocrine role

stimulates cell proliferation in epithelial cells and in cells of mesodermal origin

46
Q

EGF receptor

A

membrane glycoprotein with extracellular and intracellular components
intracellular is tyrosine kinase - autophosphorylates
when EGF binds, entire hormone-receptor complex becomes internalized

47
Q

erythropoietin

A

produced by kidneys
stimulates proliferation of primitive hematopoietic stem cells
promotes conversion of proerythrocytes to erythrocytes
regulated by states of tissue oxygenation, stimulated by hypoxia

48
Q

interleukins

A

peptide products of lymphocytes

49
Q

IL-1

A
single-chain product of monocyte macrophages
stimulates:
1: thymocyte mitosis 
2: growth of activated T-lymph
3: T-lymph reactivity
50
Q

IL-2

A

produced by lymphoid and spleen cells
formation stimulated by IL-1
stimulates growth and differentiation of lymphocytes

51
Q

IL-3

A

glycoprotein

stimulates growth and differentiation of lymphocytes

52
Q

GH effects on bone growth

A

1: widening of epiphyseal plate
2: growth of cartilage (chondrogenesis)
3: increased incorporation of sulphate into chondriotin sulphate and of proline into collagen
4: stimulates osteocyte activity => increased ossification
most activity attributed to somatomedins, but has some direct effects

53
Q

TH effects on bone growth

A

1: stimulate cartilage breakdown and bone deposition - promote bone maturation/osteogenesis

54
Q

androgens in gone growth

A

responsible for pubertal growth spurt
initially produces linear growth but then leads to increase in bone maturation and speed up closure of epiphyseal plate - cartilage formation can’t keep up with bone deposition
early maturation under influence of androgens => stunted growth
some actions indirect via peptide growth factors

55
Q

estrogens on bone growth

A

inhibit bone growth

promote closure of epiphyseal plates

56
Q

insulin on bone growth

A

necessary, but role not known

57
Q

glucocorticoids on bone growth

A

direct action - inhibitory
promote osteoporosis through decreased bone formation and increased bone resorption
directly inhibit actions of somatomedins on bone